Suppr超能文献

通过联合给予钙螯合剂增强氯环利嗪对大鼠的致畸性。

Enhancement of chlorcyclizine teratogenicity in the rat by coadministration of calcium chelating agents.

作者信息

Wilk A L, King C T, Pratt R M

出版信息

Teratology. 1978 Oct;18(2):193-8. doi: 10.1002/tera.1420180204.

Abstract

Chlorcyclizine and structurally related drugs induce a high incidence of cleft palate and skeletal malformations in fetal rats. We have shown previously that these teratogens bind tightly and reversibly to chondroitin sulfate of cartilage and compete with calcium for binding. Experiments reported here demonstrate that co-administration of calcium chelating agents with chlorcyclizine significantly increases both the frequency of malformations and retention of [14C] chlorcyclizine by embryos. Retention of radioactive teratogen by embryos is inverse to retention of [45Ca]calcium. These findings suggest that drug binding to embryonic glycosaminoglycans is involved in the pathogenesis of malformations produced by chlorcyclizine.

摘要

氯环利嗪及结构相关药物在胎鼠中诱发腭裂和骨骼畸形的发生率很高。我们之前已经表明,这些致畸剂与软骨硫酸软骨素紧密且可逆地结合,并与钙竞争结合位点。此处报道的实验表明,钙螯合剂与氯环利嗪共同给药会显著增加胚胎畸形的频率以及[14C]氯环利嗪在胚胎中的滞留量。胚胎对放射性致畸剂的滞留与[45Ca]钙的滞留呈负相关。这些发现表明,药物与胚胎糖胺聚糖的结合参与了氯环利嗪所致畸形的发病机制。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验